Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
NCT02897063Phase 1Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2016
- Primary completion
- Oct 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of droxidopa and midodrine in Neurogenic Orthostatic Hypotension (nOH), sponsored by Vanderbilt University Medical Center. Started Sep 2016; status: terminated.
02
Drugs
droxidopamidodrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT02897063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02897063.